Evidence map›Paper›PMID 27602490›Full record

ArticleOncotarget2016

Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis.

Min Zhao, Ying Chen, Guixia Ding, Ying Xu, Mi Bai, Yue Zhang, Zhanjun Jia, Songming Huang, Aihua Zhang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Hemoglobin-associatedFrontiers in medicine · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  13. 15-Deoxy-∆-PPAR research · 2019
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Min ZhaoDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Ying ChenDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Guixia DingDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Ying XuDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Mi BaiDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yue ZhangDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Zhanjun JiaDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Songming HuangDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Aihua ZhangDepartment of Nephrology, Nanjing Children's Hospital, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNNanjing Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that loss of the renal tubular epithelial phenotype plays an important role in the pathogenesis of renal tubulointerstitial fibrosis. Systemic activation of peroxisome proliferator-activated receptor γ (PPAR-γ) has been shown to be protective against renal fibrosis, although the mechanisms are poorly understood. The present study aimed to define the role of renal tubular epithelium-targeted PPAR-γ in protection of the epithelial phenotype and the antagonism of renal fibrosis and to define the underlying mechanisms. In response to TGF-β1 challenge, PPAR-γ expression and activity in the renal proximal tubule epithelial cells (RPTECs) were significantly reduced, and the reduction was accompanied by decreased E-cadherin and elevated α-SMA, indicating a loss of the epithelial phenotype. Oxidative stress induced by TGF-β1 was shown to be attributed to the alteration of the epithelial phenotype and PPAR-γ inhibition. Activation of PPAR-γ by its agonists of rosiglitazone and 15d-PGJ2 or genetic overexpression of PPAR-γ prevented the loss of the epithelial phenotype induced by TGF-β1 in line with the inhibition of oxidative stress. To explore the role of PPAR-γ in renal tubular epithelial in antagonizing fibrogenesis, PPAR-γ was specifically deleted from RPTECs in mice. Following unilateral ureteral obstruction, the fibrosis was markedly deteriorated in mice with PPAR-γ invalidation in RPTECs. Treatment with rosiglitazone attenuated tubulointerstitial fibrosis and epithelial phenotype transition in WT but not proximal tubule PPAR-γ KO mice. Taken together, these findings identified an important role of renal tubular epithelium-targeted PPAR-γ in maintaining the normal epithelial phenotype and opposing fibrogenesis, possibly via antagonizing oxidative stress.

Indexed as

AnimalsCells, CulturedFibrosisHumansKidneyKidney DiseasesMaleMiceMice, Inbred C57BLMice, KnockoutOxidative StressPhenotypePPAR gammaProstaglandin D2RosiglitazoneSignal Transduction15-deoxyprostaglandin J2PPAR gammaProstaglandin D2RosiglitazoneThiazolidinedionesTransforming Growth Factor beta1epithelial cell phenotypefibrosisPathology SectionPPAR-γrenal epithelial cellsTGF-β1

Identifiers

PMID27602490
PMCPMC5323108
OpenAlexW2515287381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.